Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Incidence, Risk Factors, and Prognostic Implications of Heart Failure Hospitalizations Among Patients with Myeloproliferative Neoplasms

Orly Leiva, Steven Soo, Nathaniel Smilowitz, Harmony Reynolds, Binita Shah, Samuel Bernard, Michelle Hyunju Lee, Chi-Joan How, Gabriela S. Hobbs

Blood (2024) 144 (Supplement 1): 3188.

https://doi.org/10.1182/blood-2024-207586

Published: 2024

Journal Articles

Prognostic Implications of Pulmonary Hypertension in Myeloproliferative Neoplasms and Predictors of Hematologic Progression

Orly Leiva, Steven Soo, Nathaniel Smilowitz, Harmony Reynolds, Binita Shah, Samuel Bernard, Michelle Hyunju Lee, Chi-Joan How, Gabriela S. Hobbs

Blood (2024) 144 (Supplement 1): 246.

https://doi.org/10.1182/blood-2024-199120

Published: 2024

Journal Articles

Myelofibrosis Is Associated with Poor Cardiovascular Outcomes after Heart Failure Hospitalization

Orly Leiva, Jose Alvarez-Cardona, Andrew M. Brunner, Chi-Joan How, Gabriela S. Hobbs

Blood (2023) 142 (Supplement 1): 3203.

https://doi.org/10.1182/blood-2023-173589

Published: 2023

Journal Articles

Outcomes of Catheter-Based Therapy for Cancer-Associated Intermediate or High-Risk Pulmonary Embolism

Orly Leiva, Eric H Yang, Rachel P. Rosovsky, Carlos Alviar, Sripal Bangalore

Blood (2023) 142 (Supplement 1): 2361.

https://doi.org/10.1182/blood-2023-187947

Published: 2023

Journal Articles

Myeloproliferative Neoplasms Are Associated with Increased Risk of Major Adverse Limb Events Among Patients Hospitalized for Peripheral Arterial Disease

Orly Leiva, Andrew M. Brunner, Joan How, Gabriela S. Hobbs, Jeffrey S Berger

Blood (2023) 142 (Supplement 1): 4570.

https://doi.org/10.1182/blood-2023-180783

Published: 2023

Journal Articles

Multicenter Retrospective Analysis of Eosinophilic Myeloid Neoplasms

Blood (2023) 142 (Supplement 1): 4576.

https://doi.org/10.1182/blood-2023-187092

Published: 2023

Journal Articles

Cardiovascular Risk Factors Are Common in Myeloproliferative Neoplasms and Portend Worse Survival and Thrombotic Outcomes

Joan How, Orly Leiva, Anna E. Marneth, Baransel Kamaz, Chulwoo J. Kim, Lachelle D. Weeks, Mohammed Wazir, Maximilian Stahl, Daniel J. DeAngelo, R. Coleman Lindsley, Marlise R. Luskin, Gabriela S. Hobbs

Blood (2023) 142 (Supplement 1): 4568.

https://doi.org/10.1182/blood-2023-179324

Published: 2023

Journal Articles

Tolerability of Direct Oral Anticoagulants and Low Molecular Weight Heparin in Patients with Brain Tumors or CNS Metastases

Emily Abdelmessih, Stephanie Wo, David L. Green, Orly Leiva, Elaine Xiang, Tania Ahuja

Blood (2023) 142 (Supplement 1): 5122.

https://doi.org/10.1182/blood-2023-187523

Published: 2023

Journal Articles

Trends in All-Cause and Cardiovascular Mortality Among Patients with Myeloproliferative Neoplasms: A Surveillance, Epidemiology, and End Results Database Analysis

Orly Leiva, Chi-Joan How, Andrew M. Brunner, Gabriela S. Hobbs

Blood (2022) 140 (Supplement 1): 6808–6809.

https://doi.org/10.1182/blood-2022-170607

Published: 2022

Journal Articles

Risk Factors for Major Adverse Cardiac Events and Bleeding in Patients with Myeloproliferative Neoplasms Admitted for Myocardial Infarction

Orly Leiva, Emaad Siddiqui, Gabriela S. Hobbs, Sripal Bangalore

Blood (2022) 140 (Supplement 1): 9729–9730.

https://doi.org/10.1182/blood-2022-157476

Published: 2022

Journal Articles

Increased Risk of Thrombosis in Patients with Myeloproliferative Neoplasms Compared with the General Population Hospitalized with COVID-19

Orly Leiva, Umberto Campia, Julia Snyder, Briana Barns, Samantha Rizzo, Candrika Khairani, Hanny Al-Samkari, Rebecca Karp Leaf, Rachel P. Rosovsky, Katayoon Goodarzi, Amir T. Fathi, Samuel Z. Goldhaber, Gregory Piazza, Gabriela Hobbs

Blood (2021) 138 (Supplement 1): 1508.

https://doi.org/10.1182/blood-2021-151801

Published: 2021

Journal Articles

Pulmonary Hypertension Is Associated with Poor Outcomes in Patients with Myeloproliferative Neoplasms and Cardiovascular Disease

Orly Leiva, Siyang Ren, Donna S. Neuberg, Ankeet Bhatt, Andrew Jenkins, Rachel P. Rosovsky, Rebecca Karp Leaf, Katayoon Goodarzi, Gabriela Hobbs

Blood (2021) 138 (Supplement 1): 3653.

https://doi.org/10.1182/blood-2021-149799

Published: 2021

Journal Articles

Rates of Thrombotic Events in Hypereosinophilic Syndrome and the Effect of Molecular Aberrations in Thrombotic Risk

Orly Leiva, MD, Olesya Baker, PhD, Andrew M. Brunner, Hanny Al-Samkari, MD, Rebecca Karp Leaf, MD, Rachel P. Rosovsky, MD MPH, Amir T. Fathi, MD, James I Weitzman, MD, Larissa Bornikova, MD, Valentina Nardi, MD, Gabriela S. Hobbs, MD

Blood (2020) 136 (Supplement 1): 14.

https://doi.org/10.1182/blood-2020-137311

Published: 2020

Journal Articles

Integrin-Mediated Adhesion to Extracellular Matrix Protein Fibronectin Drives Megakaryocytosis in JAK2 V617F+ Primary Myelofibrosis

Shinobu Matsuura, DVM,PhD, Cristal Reyna Thompson, PhD, Seng Kah Ng, PhD, Aikaterini Karagianni, MSc, Christina Ward Torres, PhD, Carla Silvana Mazzeo, PhD, Orly Leiva, MD, Alessandro Malara, PhD, Alessandra Balduini, MD, Katya Ravid, PhD DSc

Blood (2019) 134 (Supplement_1): 4205.

https://doi.org/10.1182/blood-2019-132124

Published: 2019

Journal Articles

Pregnancy Outcomes, Risk Factors, and Gestational Cell Count Trends in Pregnant Women with Essential Thrombocythemia and Polycythemia Vera

Chi-Joan How, MD, Orly Leiva, BS, Thomas Bogue, BS, Geoffrey Fell, MS, Mark Bustoros, MD, Nathan T. Connell, MD MPH, Jean M. Connors, MD, Irene M. Ghobrial, MD, Nancy Higgins, Nicholas A Jessop, David J. Kuter, Jennifer Lombardi Story, Ann Mullally, MD, Valentina Nardi, MD, Donna S Neuberg, ScD, Rachel Styles, BS, Jeffrey I. Zwicker, MD, Gabriela S. Hobbs, MD, Annemarie E Fogerty, MD

Blood (2019) 134 (Supplement_1): 4172.

https://doi.org/10.1182/blood-2019-127058

Published: 2019

Journal Articles

Black Patients Experience Highest Rates of Specific Cancer-Associated Venous Thromboembolism: A Study Based at a Large Safety-Net Hospital in New England

Nana Oduraa Addo-Tabiri, MD PhD, Rani Chudasama, MD, Rhythm Vasudeva, MBChB, Orly Leiva, MD, Brenda Garcia, MD, Jonathan Ravid, BS, Bunze Tamala, BS, Linda Rosen, MSEE, Mostafa Belghasem, MD PhD, Janice Weinberg, PhD, Ryan Ferguson, MPH, Brett Johnson, PhD, Mary Brophy, MD MPH, Vipul Chitalia, MD PhD

Blood (2018) 132 (Supplement 1): 496.

https://doi.org/10.1182/blood-2018-99-115605

Published: 2018

Journal Articles

Regulation of Lysyl Oxidase, a Key Regulator of Bone Marrow Fibrosis, in Myelofibrosis

Orly Leiva, BS, Alan B. Cantor, MD, PhD, Philip Trackman, PhD, Katya Ravid, PhD DSc

Blood (2017) 130 (Supplement 1): 1662.

https://doi.org/10.1182/blood.V130.Suppl_1.1662.1662

Published: 2017

Journal Articles

A Novel Lysyl Oxidase Inhibitor Attenuates Bone Marrow Fibrosis and Decreases Spleen Size in a Mouse Model of Primary Myelofibrosis

Orly Leiva, BS, Shinobu Matsuura, DVM,PhD, Alison Findlay, Craig Turner, Wolfgang Jarolimek, Katya Ravid, PhD DSc

Blood (2017) 130 (Supplement 1): 4214.

https://doi.org/10.1182/blood.V130.Suppl_1.4214.4214

Published: 2017

Journal Articles

Upregulation of lysyl oxidase and adhesion to collagen of human megakaryocytes and platelets in primary myelofibrosis

Vittorio Abbonante, Vipul Chitalia, Vittorio Rosti, Orly Leiva, Shinobu Matsuura, Alessandra Balduini, Katya Ravid

Blood (2017) 130 (6): 829–831.

https://doi.org/10.1182/blood-2017-04-777417

Published: 2017

Includes: Supplemental data

NARROW

Incidence, Risk Factors, and Prognostic Implications of Heart Failure Hospitalizations Among Patients with Myeloproliferative Neoplasms

Prognostic Implications of Pulmonary Hypertension in Myeloproliferative Neoplasms and Predictors of Hematologic Progression

Myelofibrosis Is Associated with Poor Cardiovascular Outcomes after Heart Failure Hospitalization

Outcomes of Catheter-Based Therapy for Cancer-Associated Intermediate or High-Risk Pulmonary Embolism

Myeloproliferative Neoplasms Are Associated with Increased Risk of Major Adverse Limb Events Among Patients Hospitalized for Peripheral Arterial Disease

Multicenter Retrospective Analysis of Eosinophilic Myeloid Neoplasms

Cardiovascular Risk Factors Are Common in Myeloproliferative Neoplasms and Portend Worse Survival and Thrombotic Outcomes

Tolerability of Direct Oral Anticoagulants and Low Molecular Weight Heparin in Patients with Brain Tumors or CNS Metastases

Trends in All-Cause and Cardiovascular Mortality Among Patients with Myeloproliferative Neoplasms: A Surveillance, Epidemiology, and End Results Database Analysis

Risk Factors for Major Adverse Cardiac Events and Bleeding in Patients with Myeloproliferative Neoplasms Admitted for Myocardial Infarction

Increased Risk of Thrombosis in Patients with Myeloproliferative Neoplasms Compared with the General Population Hospitalized with COVID-19

Pulmonary Hypertension Is Associated with Poor Outcomes in Patients with Myeloproliferative Neoplasms and Cardiovascular Disease

Rates of Thrombotic Events in Hypereosinophilic Syndrome and the Effect of Molecular Aberrations in Thrombotic Risk

Integrin-Mediated Adhesion to Extracellular Matrix Protein Fibronectin Drives Megakaryocytosis in JAK2 V617F+ Primary Myelofibrosis

Pregnancy Outcomes, Risk Factors, and Gestational Cell Count Trends in Pregnant Women with Essential Thrombocythemia and Polycythemia Vera

Black Patients Experience Highest Rates of Specific Cancer-Associated Venous Thromboembolism: A Study Based at a Large Safety-Net Hospital in New England

Regulation of Lysyl Oxidase, a Key Regulator of Bone Marrow Fibrosis, in Myelofibrosis

A Novel Lysyl Oxidase Inhibitor Attenuates Bone Marrow Fibrosis and Decreases Spleen Size in a Mouse Model of Primary Myelofibrosis

Upregulation of lysyl oxidase and adhesion to collagen of human megakaryocytes and platelets in primary myelofibrosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only